Study HZA106851: A Study of the Effects of Inhaled Fluticasone Furoate/GW642444 Versus Placebo on the HPA Axis of Adolescent and Adult Asthmatics.
Phase of Trial: Phase III
Latest Information Update: 18 Sep 2013
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Prednisolone
- Indications Asthma
- Focus Adverse reactions; Registrational
- 10 Jun 2017 Biomarkers information updated
- 21 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2010 Actual end date (September 2010) added as reported by ClinicalTrials.gov.